Catheter Ablation of Atrial Fibrillation

Heart Failure Clinics

Volumn 12, Issue 2, 2016, Pages 223-233

  Latchamsetty, Rakesh ^a   Morady, Fred ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

Atrial fibrillation; Catheter ablation; Outcomes

Indexed keywords

ANTICOAGULATION; ATRIAL FIBRILLATION; BALLOON CATHETER; CATHETER ABLATION; HUMAN; MORTALITY; PATIENT SAFETY; PATIENT SELECTION; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; ADVERSE EFFECTS; AFTERCARE; DISEASE MANAGEMENT; ELECTROCARDIOGRAPHY; HEART MUSCLE CONDUCTION SYSTEM; PATHOPHYSIOLOGY; PROCEDURES;

AFTERCARE; ATRIAL FIBRILLATION; CATHETER ABLATION; DISEASE MANAGEMENT; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HUMANS; TREATMENT OUTCOME;

EID: 84960127460     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2015.08.018     Document Type: Review

References (63)

1. January C.T., Wann L.S., Alpert J.S., et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2014, [Epub ahead of print].
2. Di Biase L., Burkhardt D., Santangeli P., et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the "COMPARE" randomized trial. Circulation 2014, 129(25):2638-2644.
3. Latchamsetty R., Gautam S., Bhakta D., et al. Management and outcomes of cardiac tamponade during atrial fibrillation ablation in the presence of therapeutic anticoagulation with warfarin. Heart Rhythm 2011, 8:805-808.
4. Lakkireddy D., Reddy Y.M., Di Biase L., et al. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. J Am Coll Cardiol 2014, 63:982-988.
5. Jalife J. Rotors and spiral waves in atrial fibrillation. J Cardiovasc Electrophysiol 2003, 14:776-780.
6. Po S.S., Nakagawa H., Jackman W.M. Localization of left atrial ganglionated plexi in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2009, 20:1186-1189.
7. Zipes D., Jalife J. Cardiac electrophysiology, from cell to bedside 2013, Saunders Elsevier, Philadelphia.
8. H W.Studien über herzflimmern I. Über die wirkung des n. Vagus und accelerans auf das flimmern des herzens 1907, 223-256. M. Hager, Bonn.
9. Mines G.R. On dynamic equilibrium in the heart. J Physiol 1913, 46:349-383.
10. Moe G.K. A conceptual model of atrial fibrillation. J Electrocardiol 1968, 1:145-146.
11. Haïssaguerre M., Jaïs P., Shah D.C., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998, 339:659-666.
12. Oral H., Ozaydin M., Chugh A., et al. Role of the coronary sinus in maintenance of atrial fibrillation. J Cardiovasc Electrophysiol 2003, 14:1329-1336.
13. Kim D.T., Lai A.C., Hwang C., et al. The ligament of Marshall: a structural analysis in human hearts with implications for atrial arrhythmias. J Am Coll Cardiol 2000, 36:1324-1327.
14. Lin W.S., Tai C.T., Hsieh M.H., et al. Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation 2003, 107:3176-3183.
15. Jalife J., Berenfeld O., Mansour M. Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. Cardiovasc Res 2002, 54:204-216.
16. Kalifa J., Tanaka K., Zaitsev A.V., et al. Mechanisms of wave fractionation at boundaries of high-frequency excitation in the posterior left atrium of the isolated sheep heart during atrial fibrillation. Circulation 2006, 113:626-633.
17. Bettoni M., Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation 2002, 105:2753-2759.
18. Po S.S., Scherlag B.J., Yamanashi W.S., et al. Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions. Heart Rhythm 2006, 3:201-208.
19. Douglas Y.L., Jongbloed M.R., Gittenberger-de Groot A.C., et al. Histology of vascular myocardial wall of left atrial body after pulmonary venous incorporation. Am J Cardiol 2006, 97:662-670.
20. Oral H., Pappone C., Chugh A., et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006, 354:934-941.
21. Oral H., Chugh A., Yoshida K., et al. A randomized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation. J Am Coll Cardiol 2009, 53:782-789.
22. Jiang R.H., Po S.S., Tung R., et al. Incidence of pulmonary vein conduction recovery in patients without clinical recurrence after ablation of paroxysmal atrial fibrillation: mechanistic implications. Heart Rhythm 2014, 11:969-976.
23. Pappone C., Augello G., Sala S., et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF study. J Am Coll Cardiol 2006, 48:2340-2347.
24. Wazni O.M., Marrouche N.F., Martin D.O., et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005, 293:2634-2640.
25. Nademanee K., McKenzie J., Kosar E., et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004, 43:2044-2053.
26. Lin J., Scherlag B.J., Zhou J., et al. Autonomic mechanism to explain complex fractionated atrial electrograms (CFAE). J Cardiovasc Electrophysiol 2007, 18:1197-1205.
27. Segerson N.M., Daccarett M., Badger T.J., et al. Magnetic resonance imaging-confirmed ablative debulking of the left atrial posterior wall and septum for treatment of persistent atrial fibrillation: rationale and initial experience. J Cardiovasc Electrophysiol 2010, 21:126-132.
28. Knecht S., Hocini M., Wright M., et al. Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur Heart J 2008, 29:2359-2366.
29. Nishida K., Sarrazin J.F., Fujiki A., et al. Roles of the left atrial roof and pulmonary veins in the anatomic substrate for persistent atrial fibrillation and ablation in a canine model. J Am Coll Cardiol 2010, 56:1728-1736.
30. Hwang C., Chen P.S. Ligament of Marshall: why it is important for atrial fibrillation ablation. Heart Rhythm 2009, 6:S35-S40.
31. Matsuo S., Wright M., Knecht S., et al. Peri-mitral atrial flutter in patients with atrial fibrillation ablation. Heart Rhythm 2010, 7:2-8.
32. Zhou Q., Hou Y., Yang S. A meta-analysis of the comparative efficacy of ablation for atrial fibrillation with and without ablation of the ganglionated plexi. Pacing Clin Electrophysiol 2011, 34:1687-1694.
33. Atienza F., Almendral J., Jalife J., et al. Real-time dominant frequency mapping and ablation of dominant frequency sites in atrial fibrillation with left-to-right frequency gradients predicts long-term maintenance of sinus rhythm. Heart Rhythm 2009, 6:33-40.
34. Lin Y.J., Tsao H.M., Chang S.L., et al. Role of high dominant frequency sites in nonparoxysmal atrial fibrillation patients: insights from high-density frequency and fractionation mapping. Heart Rhythm 2010, 7:1255-1262.
35. Sanders P., Berenfeld O., Hocini M., et al. Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans. Circulation 2005, 112:789-797.
36. Narayan S.M., Krummen D.E., Shivkumar K., et al. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol 2012, 60(7):628-636.
37. Narayan S.M., Baykaner T., Clopton P., et al. Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation). J Am Coll Cardiol 2014, 63:1761-1768.
38. Faustino M., Pizzi C., Capuzzi D., et al. The impact of atrial fibrillation termination mode during catheter ablation procedure on maintenance of sinus rhythm. Heart Rhythm 2014, [Epub ahead of print].
39. Schmidt M., Dorwarth U., Andresen D., et al. Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German ablation registry. J Cardiovasc Electrophysiol 2014, 25:1-7.
40. Kojodjojo P., O'Neill M.D., Lim P.B., et al. Pulmonary venous isolation by antral ablation with a large cryoballoon for treatment of paroxysmal and persistent atrial fibrillation: medium-term outcomes and non-randomised comparison with pulmonary venous isolation by radiofrequency ablation. Heart 2010, 96:1379-1384.
41. Packer D.L., Kowal R.C., Wheelan K.R., et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol 2013, 61:1713-1723.
42. Andrade J.G., Khairy P., Guerra P.G., et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm 2011, 8:1444-1451.
43. Stöckigt F., Schrickel J.W., Andrié R., et al. Atrioesophageal fistula after cryoballoon pulmonary vein isolation. J Cardiovasc Electrophysiol 2012, 23:1254-1257.
44. Metzner A., Burchard A., Wohlmuth P., et al. Increased incidence of esophageal thermal lesions using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol 2013, 6:769-775.
45. Calkins H., Kuck K.H., Cappato R., et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm 2012, 9:632-696.e21.
46. Jaïs P., Cauchemez B., Macle L., et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008, 118:2498-2505.
47. Oral H., Chugh A., Good E., et al. A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation 2006, 113:1824-1831.
48. Cappato R., Calkins H., Chen S.A., et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010, 3:32-38.
49. Brooks A.G., Stiles M.K., Laborderie J., et al. Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart Rhythm 2010, 7:835-846.
50. Latchamsetty R., Morady F. Long-term benefits following catheter ablation of atrial fibrillation. Circ J 2013, 77:1091-1096.
51. Ouyang F., Tilz R., Chun J., et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation 2010, 122:2368-2377.
52. Medi C., Sparks P.B., Morton J.B., et al. Pulmonary vein antral isolation for paroxysmal atrial fibrillation: results from long-term follow-up. J Cardiovasc Electrophysiol 2011, 22:137-141.
53. Benjamin E.J., Wolf P.A., D'Agostino R.B., et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998, 98:946-952.
54. Ghanbari H., Baser K., Jongnarangsin K., et al. Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm 2014, [Epub ahead of print].
55. Gage B.F., Waterman A.D., Shannon W., et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001, 285:2864-2870.
56. Bunch T.J., May H.T., Bair T.L., et al. Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score. Heart Rhythm 2013, 10:1272-1277.
57. Themistoclakis S., Corrado A., Marchlinski F.E., et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol 2010, 55:735-743.
58. Lip G.Y., Nieuwlaat R., Pisters R., et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest 2010, 137:263-272.
59. Pisters R., Lane D.A., Nieuwlaat R., et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010, 138:1093-1100.
60. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
61. Cappato R., Calkins H., Chen S.A., et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005, 111:1100-1105.
62. Deshmukh A., Patel N.J., Pant S., et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the united states between 2000 and 2010: analysis of 93 801 procedures. Circulation 2013, 128:2104-2112.
63. Arbelo E., Brugada J., Hindricks G., Atrial Fibrillation Ablation Pilot Study Investigators, et al. The Atrial Fibrillation Ablation Pilot Study: a European survey on methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association. Eur Heart J 2014, 35(22):1466-1478.